Company Filing History:
Years Active: 2012
Title: Gerhard Schaenze: Innovator in Pharmaceutical Research
Introduction
Gerhard Schaenze is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific health conditions. His work focuses on the modulation of PI3-kinases, which play a crucial role in various inflammatory and allergic diseases.
Latest Patents
Gerhard Schaenze holds a patent for "Inhibitors of PI3-kinases." This patent introduces new compounds of formula 1 that exhibit pharmaceutical activity as PI3-kinase modulators. These compounds may be utilized in the therapeutic field for treating a range of inflammatory or allergic diseases. Examples of these conditions include inflammatory and allergic respiratory complaints, inflammatory diseases of the gastrointestinal tract and motor apparatus, as well as inflammatory and allergic skin diseases. Additionally, the compounds may address inflammatory eye diseases, diseases of the nasal mucosa, and conditions involving autoimmune reactions or kidney inflammation.
Career Highlights
Gerhard Schaenze is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at this organization has allowed him to contribute to innovative solutions in healthcare. His research has the potential to improve the quality of life for individuals suffering from various inflammatory and allergic conditions.
Collaborations
Throughout his career, Gerhard has collaborated with esteemed colleagues, including Steffen Breitfelder and Udo Maier. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Gerhard Schaenze's contributions to pharmaceutical research, particularly in the area of PI3-kinase inhibitors, highlight his commitment to addressing significant health challenges. His innovative work continues to pave the way for advancements in the treatment of inflammatory and allergic diseases.